The prognostic relevance of Her3 was assessed using a multivariate proportional hazard model adjusted for the clinicopathologic parameters of age, gender, histological grading, primary tumor sites and, lymph node metastasis. Here, ERBB3 is linked to metastatic malignant neoplasm in the lymph nodes.